Annelise Vuidepot

Company: Immunocore

Job title: Chief Technology Officer

Seminars:

Harnessing TCR Bispecifics to Tackle Autoimmune Diseases 9:00 am

• Adapting the ImmTAX platform to address autoimmune diseases • First clinical programme for the treatment of Type I diabetesRead more

day: Day 2

Industry Leaders’ Fireside Chat: A Commercial TCR-T & TCR Bispecific – What’s Next? 2:15 pm

• Reflecting on the past: celebrating the first TCR-T commercial approval and its impact on the field, along with novel clinical data • Determining the current state of play: discussing what challenges remain, the current funding environment and the priority for the field to outline present focus • What’s next? Discussing the potential for allogeneic…Read more

day: Day 1